Crossmark

Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study

Crossref DOI link: https://doi.org/10.1007/s00198-021-05823-8

Published Online: 2021-01-18

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, C.S.

Feasel, A.L.

Kline, G.A.

Billington, E.O. https://orcid.org/0000-0002-2556-588X
Funding

Funding for this research was provided by:

Alberta Innovates - Health Solutions
License Information

Text and Data Mining valid from 2021-01-18

Version of Record valid from 2021-01-18
More Information

Article History

Received: 22 September 2020

Accepted: 4 January 2021

First Online: 18 January 2021

Compliance with ethical standards

:

: CSL, ALF, and GAK declare that they have no conflict of interest. EOB has previously received honoraria from Amgen and Eli Lilly and a research grant from Amgen outside of the submitted work.

: Approval was granted from the University of Calgary Conjoint Health Research Ethics Board (REB16-0390).

: N/A

: N/A

: N/A

Document is current

Any future updates will be listed below